|
" Biopharmaceuticals, an Industrial Perspective. "
Gary Walsh
| Document Type
|
:
|
BL
|
| Record Number
|
:
|
776596
|
| Doc. No
|
:
|
b596593
|
| Main Entry
|
:
|
Gary Walsh
|
| Title & Author
|
:
|
Biopharmaceuticals, an Industrial Perspective.\ Gary Walsh
|
| Publication Statement
|
:
|
Dordrecht : Springer Netherlands, 2010
|
| Page. NO
|
:
|
(514 pages)
|
| ISBN
|
:
|
9401709262
|
|
|
:
|
: 9789401709262
|
| Contents
|
:
|
Contributors; Acknowledgements; Preface; Chapter 1 Biopharmaceuticals, an overview; Chapter 2 Abciximab: The First Platelet Glycoprotein IIb/IlIa Receptor Antagonist; Chapter 3 Recombinant Coagulation Factor IX (BeneFIX@); Chapter 4 Biopbarmaceutical Drug Development: A Case History; Chapter 5 Follitropin beta (puregon); Chapter 6 Insulin Lispro (Humalog); Chapter 7 Interferon beta-1b --; the first long-term effective treatment of relapsing-remitting and secondary progressive multiple sclerosis (MS); Chapter 8 Reteplase, a recombinant plasminogen activator. Chapter 9 Stabilisation of biopharmaceutical products and finished product formulationsChapter 10 Patent Law for Biopbarmaceuticals; Chapter 11 The development of new medicines: an overview; Chapter 12 The EMEA and regulatory control of(bio)pharmaceuticals within the European Union; Chapter 13 Biopbarmaceutical Validation: an overview; Chapter 14 Validation of Biopharmaceutical Chromatography Systems; Chapter 15 Validation of Water for Injections (WFI) for Biopbarmaceutical Manufacture; Chapter 16 Information retrieval and the biopharmaceutical industry: an introductory overview. Chapter 17 Information technology and the internet as a resource of biopharmaceutical informationChapter 18 Marketing Issues for tbe (Bio)pbarmaceuticaJ sector; Chapter 19 Viral mediated gene therapy; Chapter 20 Pharmaceutical gene medicines for non-viral gene therapy; Index.
|
| Subject
|
:
|
Biotechnology.
|
| LC Classification
|
:
|
RS380.G379 2010
|
| Added Entry
|
:
|
Brendan Murphy
|
|
|
:
|
Gary Walsh
|
| |